# Safety of Sildenafil in Premature Infants

> **NCT03142568** · PHASE2 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 109 (actual)

## Conditions studied

- Bronchopulmonary Dysplasia

## Interventions

- **DRUG:** Sildenafil
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03142568
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-02
- **Primary completion:** 2025-03-01
- **Final completion:** 2025-03-01
- **Target enrollment:** 109 (ACTUAL)
- **Last updated:** 2026-03-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03142568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03142568, "Safety of Sildenafil in Premature Infants". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03142568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*